Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ACAD |
---|---|---|
09:32 ET | 61992 | 16.19 |
09:34 ET | 3070 | 16.29 |
09:36 ET | 1500 | 16.3 |
09:38 ET | 1350 | 16.205 |
09:39 ET | 1518 | 16.23 |
09:41 ET | 7395 | 16.19 |
09:43 ET | 670 | 16.13 |
09:45 ET | 822 | 16.11 |
09:48 ET | 520 | 16.12 |
09:50 ET | 1100 | 16.14 |
09:52 ET | 4895 | 16.1608 |
09:54 ET | 3728 | 16.08 |
09:56 ET | 336 | 16.06 |
09:57 ET | 700 | 16.07 |
09:59 ET | 853 | 16.05 |
10:01 ET | 4636 | 16.076 |
10:06 ET | 1345 | 16.05 |
10:08 ET | 900 | 16.06 |
10:10 ET | 2401 | 16.075 |
10:12 ET | 500 | 16.04 |
10:14 ET | 634 | 16.05 |
10:15 ET | 400 | 16.04 |
10:17 ET | 1039 | 16.01 |
10:19 ET | 5560 | 16.05 |
10:21 ET | 959 | 16.02 |
10:24 ET | 738 | 16.01 |
10:26 ET | 200 | 16.0084 |
10:28 ET | 100 | 16 |
10:30 ET | 500 | 16 |
10:32 ET | 964 | 15.99 |
10:33 ET | 1013 | 15.97 |
10:35 ET | 2782 | 15.9909 |
10:37 ET | 2707 | 16.03 |
10:39 ET | 1462 | 16.02 |
10:42 ET | 3425 | 16.04 |
10:44 ET | 1721 | 16.03 |
10:46 ET | 1289 | 15.99 |
10:50 ET | 100 | 15.98 |
10:51 ET | 100 | 15.98 |
10:53 ET | 2263 | 16 |
10:55 ET | 1329 | 16.02 |
10:57 ET | 1839 | 16.01 |
11:00 ET | 5743 | 16.02 |
11:02 ET | 1034 | 16 |
11:04 ET | 684 | 15.995 |
11:06 ET | 747 | 15.98 |
11:08 ET | 1840 | 15.94 |
11:11 ET | 1684 | 15.94 |
11:13 ET | 1100 | 15.96 |
11:15 ET | 1387 | 15.97 |
11:18 ET | 100 | 15.97 |
11:20 ET | 2916 | 15.95 |
11:22 ET | 100 | 15.95 |
11:24 ET | 906 | 15.94 |
11:26 ET | 200 | 15.96 |
11:27 ET | 100 | 15.95 |
11:29 ET | 1483 | 15.95 |
11:31 ET | 418 | 15.96 |
11:33 ET | 650 | 15.95 |
11:36 ET | 1148 | 15.94 |
11:38 ET | 200 | 15.93 |
11:40 ET | 200 | 15.935 |
11:42 ET | 700 | 15.93 |
11:45 ET | 100 | 15.925 |
11:47 ET | 100 | 15.91 |
11:49 ET | 1011 | 15.8966 |
11:51 ET | 17663 | 15.87 |
11:54 ET | 2938 | 15.93 |
11:56 ET | 950 | 15.94 |
11:58 ET | 1458 | 15.94 |
12:00 ET | 1900 | 15.93 |
12:02 ET | 1500 | 15.88 |
12:03 ET | 1209 | 15.89 |
12:05 ET | 3423 | 15.91 |
12:07 ET | 848 | 15.92 |
12:09 ET | 700 | 15.93 |
12:12 ET | 600 | 15.92 |
12:14 ET | 1049 | 15.89 |
12:16 ET | 717 | 15.88 |
12:18 ET | 330 | 15.88 |
12:20 ET | 3306 | 15.8899 |
12:21 ET | 784 | 15.89 |
12:23 ET | 200 | 15.89 |
12:25 ET | 1450 | 15.88 |
12:27 ET | 10510 | 15.87 |
12:30 ET | 1513 | 15.85 |
12:32 ET | 1510 | 15.855 |
12:34 ET | 1257 | 15.85 |
12:36 ET | 500 | 15.83 |
12:38 ET | 1148 | 15.83 |
12:39 ET | 912 | 15.83 |
12:41 ET | 250 | 15.83 |
12:43 ET | 1775 | 15.84 |
12:45 ET | 1703 | 15.8326 |
12:50 ET | 6684 | 15.825 |
12:52 ET | 500 | 15.83 |
12:54 ET | 1357 | 15.7905 |
12:56 ET | 1795 | 15.77 |
12:57 ET | 1589 | 15.77 |
12:59 ET | 489 | 15.76 |
01:01 ET | 1433 | 15.7723 |
01:03 ET | 1813 | 15.77 |
01:06 ET | 3204 | 15.7975 |
01:08 ET | 1900 | 15.79 |
01:10 ET | 1713 | 15.82 |
01:12 ET | 6486 | 15.81 |
01:14 ET | 500 | 15.8 |
01:15 ET | 600 | 15.8 |
01:17 ET | 1399 | 15.8 |
01:19 ET | 400 | 15.79 |
01:21 ET | 3006 | 15.79 |
01:24 ET | 601 | 15.78 |
01:26 ET | 1150 | 15.77 |
01:28 ET | 500 | 15.78 |
01:30 ET | 900 | 15.77 |
01:32 ET | 13504 | 15.78 |
01:33 ET | 2269 | 15.78 |
01:35 ET | 3308 | 15.77 |
01:37 ET | 2626 | 15.78 |
01:39 ET | 1338 | 15.795 |
01:42 ET | 528 | 15.8 |
01:44 ET | 3423 | 15.77 |
01:46 ET | 100 | 15.78 |
01:48 ET | 932 | 15.79 |
01:50 ET | 100 | 15.785 |
01:51 ET | 1029 | 15.8 |
01:53 ET | 2383 | 15.81 |
01:55 ET | 2200 | 15.85 |
02:00 ET | 1100 | 15.84 |
02:02 ET | 586 | 15.83 |
02:04 ET | 1002 | 15.85 |
02:06 ET | 400 | 15.84 |
02:08 ET | 1000 | 15.86 |
02:09 ET | 400 | 15.86 |
02:13 ET | 100 | 15.865 |
02:15 ET | 888 | 15.855 |
02:18 ET | 600 | 15.845 |
02:22 ET | 1800 | 15.84 |
02:24 ET | 1180 | 15.86 |
02:26 ET | 1670 | 15.87 |
02:27 ET | 500 | 15.89 |
02:29 ET | 3054 | 15.88 |
02:31 ET | 200 | 15.87 |
02:33 ET | 500 | 15.88 |
02:36 ET | 3111 | 15.93 |
02:38 ET | 800 | 15.93 |
02:40 ET | 100 | 15.92 |
02:42 ET | 1932 | 15.925 |
02:44 ET | 1626 | 15.936 |
02:45 ET | 2155 | 15.925 |
02:47 ET | 2451 | 15.95 |
02:49 ET | 200 | 15.96 |
02:51 ET | 400 | 15.96 |
02:54 ET | 1700 | 15.93 |
02:56 ET | 1200 | 15.93 |
02:58 ET | 2512 | 15.93 |
03:00 ET | 100 | 15.94 |
03:02 ET | 1500 | 15.93 |
03:03 ET | 2000 | 15.93 |
03:05 ET | 2716 | 15.9 |
03:07 ET | 1028 | 15.895 |
03:09 ET | 2628 | 15.88 |
03:12 ET | 2200 | 15.84 |
03:14 ET | 2853 | 15.835 |
03:16 ET | 4215 | 15.86 |
03:18 ET | 4218 | 15.855 |
03:20 ET | 600 | 15.85 |
03:21 ET | 2802 | 15.85 |
03:23 ET | 1300 | 15.85 |
03:25 ET | 3350 | 15.87 |
03:27 ET | 2218 | 15.9 |
03:30 ET | 5876 | 15.925 |
03:32 ET | 4789 | 15.87 |
03:34 ET | 3028 | 15.85 |
03:36 ET | 3608 | 15.865 |
03:38 ET | 2200 | 15.845 |
03:39 ET | 2557 | 15.83 |
03:41 ET | 2502 | 15.86 |
03:43 ET | 1284 | 15.855 |
03:45 ET | 1400 | 15.87 |
03:48 ET | 5716 | 15.86 |
03:50 ET | 7999 | 15.83 |
03:52 ET | 7405 | 15.825 |
03:54 ET | 5082 | 15.85 |
03:56 ET | 12138 | 15.83 |
03:57 ET | 27063 | 15.85 |
03:59 ET | 32415 | 15.84 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
ACADIA Pharmaceuticals Inc | 2.6B | -1,230.8x | --- |
Azenta Inc | 2.8B | -18.8x | --- |
PTC Therapeutics Inc | 2.3B | -4.0x | --- |
Guardant Health Inc | 3.5B | -7.4x | --- |
Amicus Therapeutics Inc | 2.9B | -20.0x | --- |
Novavax Inc | 1.8B | -4.1x | --- |
Acadia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders and rare diseases. Its pipeline includes NUPLAZID (pimavanserin), DAYBUE (trofinetide), ACP-101, ACP-204, and Antisense Oligonucleotide (ASO) Programs. NUPLAZID is a selective serotonin inverse agonist/antagonist preferentially targeting the 5-HT2A receptor. NUPLAZID is developed for the treatment for Parkinson's Disease Psychosis. Trofinetide is a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 (IGF-1) designed to treat the core symptoms of Rett syndrome by reducing neuroinflammation and supporting synaptic function.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.6B |
---|---|
Revenue (TTM) | $813.8M |
Shares Outstanding | 165.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.38 |
EPS | $-0.01 |
Book Value | $2.62 |
P/E Ratio | -1,230.8x |
Price/Sales (TTM) | 3.2 |
Price/Cash Flow (TTM) | 292.6x |
Operating Margin | -0.56% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.